Promising Results from Clinical Trial for Stem-Cell-Based Gene Therapy for Beta-Thalassemia
Belova59 / Pixabay

Promising Results from Clinical Trial for Stem-Cell-Based Gene Therapy for Beta-Thalassemia

According to a recent article, a new stem-cell-based gene therapy is showing promising results for treating beta (β)-thalassemia in a phase 1 clinical trial. Beta Thalassemia Beta thalassemia is a…

Continue Reading Promising Results from Clinical Trial for Stem-Cell-Based Gene Therapy for Beta-Thalassemia
Graduate Raises Hypophosphatasia Awareness
https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

Graduate Raises Hypophosphatasia Awareness

When she was born, Savannha Aretino was diagnosed with hypophosphatasia, a rare genetic disorder characterized by bone and teeth development abnormalities. Now, twenty-three years later, Savannha is working to not…

Continue Reading Graduate Raises Hypophosphatasia Awareness
Gene Therapy Reduces Need for Transfusions in Patients with Beta-Thalassemia
source: pixabay.com

Gene Therapy Reduces Need for Transfusions in Patients with Beta-Thalassemia

According to a recent article, a study shows that treatment with gene therapy reduces the need for patients with non-β0/ β0 genotype Beta-thalassemia (β-thalassemia)to get transfusions. Beta-thalassemia (β-thalassemia) Beta thalassemia…

Continue Reading Gene Therapy Reduces Need for Transfusions in Patients with Beta-Thalassemia
An Opportunity for Junior Investigators to Make an Impact on PAH Research
https://pixabay.com/photos/student-notebook-female-study-type-865073/

An Opportunity for Junior Investigators to Make an Impact on PAH Research

The Pulmonary Hypertension Association recently announced it is offering junior investigators who are interested in pulmonary arterial hypertension (PAH) a two-year grant. Pulmonary Arterial Hypertension (PAH) Pulmonary arterial hypertension (PAH)…

Continue Reading An Opportunity for Junior Investigators to Make an Impact on PAH Research
Familial Chylomicronemia Syndrome Treatment is Given Category 1 Classification in Brazil
source: pixabay.com

Familial Chylomicronemia Syndrome Treatment is Given Category 1 Classification in Brazil

PTC Therapeutics has just announced that their therapy Waylivra (volanesorsen), a treatment for familial chylomicronemia syndrome (FCS), has been given Category 1 classification from the Drug Market Regulation Chamber in…

Continue Reading Familial Chylomicronemia Syndrome Treatment is Given Category 1 Classification in Brazil
Phase 2 Fabry Disease Clinical Trial Has Been Stopped Due to Negative Outcomes
source: pixabay.com

Phase 2 Fabry Disease Clinical Trial Has Been Stopped Due to Negative Outcomes

Avrobio has just announced that they will be stopping work on their investigative gene therapy for Fabry disease based on unexpected and disappointing results from a Phase 2 clinical trial.…

Continue Reading Phase 2 Fabry Disease Clinical Trial Has Been Stopped Due to Negative Outcomes
Patients with Benign Adrenal Tumors or Cushing Syndrome are More Likely to Face Type 2 Diabetes or Hypertension
source: pixabay.com

Patients with Benign Adrenal Tumors or Cushing Syndrome are More Likely to Face Type 2 Diabetes or Hypertension

The largest study of benign adrenal tumors has just been completed. Results have been published in the Annals of Internal Medicine. Specifically, this study examined the effect of mild autonomous cortisol…

Continue Reading Patients with Benign Adrenal Tumors or Cushing Syndrome are More Likely to Face Type 2 Diabetes or Hypertension
Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis
source: pixabay.com

Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis is a liver disease, causing fat to build up in the liver. The resulting inflammation may lead to liver cancer or cirrhosis (scarring) and possible liver failure. As…

Continue Reading Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis